These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20021285)

  • 1. Picornaviral 3C protease inhibitors and the dual 3C protease/coronaviral 3C-like protease inhibitors.
    Wang HM; Liang PH
    Expert Opin Ther Pat; 2010 Jan; 20(1):59-71. PubMed ID: 20021285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discovery.
    Ramajayam R; Tan KP; Liang PH
    Biochem Soc Trans; 2011 Oct; 39(5):1371-5. PubMed ID: 21936817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections.
    Wang QM
    Prog Drug Res; 1999; 52():197-219. PubMed ID: 10396129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections.
    Wang QM
    Prog Drug Res; 2001; Spec No():229-53. PubMed ID: 11548209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad-spectrum inhibitors against 3C-like proteases of feline coronaviruses and feline caliciviruses.
    Kim Y; Shivanna V; Narayanan S; Prior AM; Weerasekara S; Hua DH; Kankanamalage AC; Groutas WC; Chang KO
    J Virol; 2015 May; 89(9):4942-50. PubMed ID: 25694593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses.
    Kim Y; Lovell S; Tiew KC; Mandadapu SR; Alliston KR; Battaile KP; Groutas WC; Chang KO
    J Virol; 2012 Nov; 86(21):11754-62. PubMed ID: 22915796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of the Picornaviral 3C Proteinase in the Viral Life Cycle and Host Cells.
    Sun D; Chen S; Cheng A; Wang M
    Viruses; 2016 Mar; 8(3):82. PubMed ID: 26999188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of a cell-based protease assay for testing inhibitors of picornavirus 3C proteases.
    van der Linden L; Ulferts R; Nabuurs SB; Kusov Y; Liu H; George S; Lacroix C; Goris N; Lefebvre D; Lanke KH; De Clercq K; Hilgenfeld R; Neyts J; van Kuppeveld FJ
    Antiviral Res; 2014 Mar; 103():17-24. PubMed ID: 24393668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors.
    Ramajayam R; Tan KP; Liu HG; Liang PH
    Bioorg Med Chem; 2010 Nov; 18(22):7849-54. PubMed ID: 20947359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Target Pocket Similarity and Progress into Research on Inhibitors of Picornavirus 3C Proteases.
    Wan L; Wang X; Wang T; Yuan X; Liu W; Huang Y; Deng C; Cao S
    Chem Biodivers; 2023 Mar; 20(3):e202201100. PubMed ID: 36808685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3C protease of enterovirus 68: structure-based design of Michael acceptor inhibitors and their broad-spectrum antiviral effects against picornaviruses.
    Tan J; George S; Kusov Y; Perbandt M; Anemüller S; Mesters JR; Norder H; Coutard B; Lacroix C; Leyssen P; Neyts J; Hilgenfeld R
    J Virol; 2013 Apr; 87(8):4339-51. PubMed ID: 23388726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human rhinovirus 3C protease as a potential target for the development of antiviral agents.
    Wanga QM; Chen SH
    Curr Protein Pept Sci; 2007 Feb; 8(1):19-27. PubMed ID: 17305557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual and common inhibitors of coronavirus and picornavirus main proteases.
    Kuo CJ; Liu HG; Lo YK; Seong CM; Lee KI; Jung YS; Liang PH
    FEBS Lett; 2009 Feb; 583(3):549-55. PubMed ID: 19166843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immune evasion mediated by picornaviral 3C protease: Possible lessons for coronaviral 3C-like protease?
    Ng CS; Stobart CC; Luo H
    Rev Med Virol; 2021 Sep; 31(5):1-22. PubMed ID: 33624382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of quinone analogues as potential inhibitors of picornavirus 3C protease in vitro.
    Jung E; Lee JY; Kim HJ; Ryu CK; Lee KI; Kim M; Lee CK; Go YY
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2533-2538. PubMed ID: 29866517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.
    Binford SL; Maldonado F; Brothers MA; Weady PT; Zalman LS; Meador JW; Matthews DA; Patick AK
    Antimicrob Agents Chemother; 2005 Feb; 49(2):619-26. PubMed ID: 15673742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of 3C cysteine proteinases from Picornaviridae.
    Lall MS; Jain RP; Vederas JC
    Curr Top Med Chem; 2004; 4(12):1239-53. PubMed ID: 15320724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting zoonotic viruses: Structure-based inhibition of the 3C-like protease from bat coronavirus HKU4--The likely reservoir host to the human coronavirus that causes Middle East Respiratory Syndrome (MERS).
    St John SE; Tomar S; Stauffer SR; Mesecar AD
    Bioorg Med Chem; 2015 Sep; 23(17):6036-48. PubMed ID: 26190463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational modeling of the bat HKU4 coronavirus 3CL
    Abuhammad A; Al-Aqtash RA; Anson BJ; Mesecar AD; Taha MO
    J Mol Recognit; 2017 Nov; 30(11):. PubMed ID: 28608547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent inhibition of feline coronaviruses with peptidyl compounds targeting coronavirus 3C-like protease.
    Kim Y; Mandadapu SR; Groutas WC; Chang KO
    Antiviral Res; 2013 Feb; 97(2):161-8. PubMed ID: 23219425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.